Candel Therapeutics, Inc.

8-K Shareholder vote results Jun 24, 2026 8-K Director or officer change Jun 16, 2026 8-K Regulation FD disclosure May 15, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release) May 14, 2026 10-K Fiscal year ended 2025-12-31 Mar 12, 2026 8-K Results of operations (earnings release) Mar 12, 2026 8-K Entered a material agreement; Other events Feb 23, 2026 8-K Entered a material agreement; Results of operations (earnings release); Regulation FD disclosure; Other events Feb 19, 2026 8-K Regulation FD disclosure Dec 5, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release) Nov 13, 2025 8-K Entered a material agreement; Results of operations (earnings release); Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure; Other events Oct 14, 2025 8-K Entered a material agreement Aug 21, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Entered a material agreement; Regulation FD disclosure Jun 24, 2025 8-K Director or officer change; Regulation FD disclosure Jun 23, 2025 8-K Shareholder vote results Jun 18, 2025 8-K Director or officer change; Regulation FD disclosure Jun 6, 2025 8-K Regulation FD disclosure; Other events May 28, 2025 8-K Regulation FD disclosure May 22, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release) May 13, 2025 8-K Regulation FD disclosure Apr 23, 2025 8-K Regulation FD disclosure; Other events Mar 27, 2025 10-K Fiscal year ended 2024-12-31 Mar 13, 2025 8-K Results of operations (earnings release) Mar 13, 2025 8-K Regulation FD disclosure; Other events Feb 25, 2025 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Jan 13, 2025 8-K Entered a material agreement; Other events Dec 13, 2024 8-K Regulation FD disclosure; Other events Dec 11, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 14, 2024 8-K Regulation FD disclosure; Other events Oct 28, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Results of operations (earnings release) Aug 13, 2024 8-K Shareholder vote results Jun 28, 2024 8-K Amended charter or bylaws May 30, 2024 8-K Regulation FD disclosure; Other events May 23, 2024